Archive · 24 Nov 2025
JM Financial Recommends 3 Stocks with High Upside
JM Financial, a domestic brokerage house, has recommended three stocks with significant upside potential.
They have given a 'Buy' rating to Dr Reddy’s Laboratories, expecting a 22% upside due to growth in various markets and products.
Mahindra & Mahindra received an 'Add' rating with an 8.5% upside, driven by strong positioning in automotive and farm equipment.
Eternal (Zomato) was also given a 'Buy' rating with a 50% upside potential, primarily due to the growth of Blinkit and shifts in consumer purchases.
Each stock is expected to benefit from specific growth drivers in their respective sectors.
JM Financial recommends Dr Reddy’s Laboratories with a 'Buy' rating and 22% upside potential.
Mahindra & Mahindra receives an 'Add' rating with 8.5% upside potential, driven by automotive and farm equipment growth.
Eternal (Zomato) is given a 'Buy' rating with 50% upside potential, primarily due to Blinkit's growth.
Dr Reddy’s Laboratories' growth is expected from NRT business, biosimilar launches, and pipeline products.
Mahindra & Mahindra aims for significant revenue growth in automotive and farm equipment sectors by FY30.
- Who
- JM Financial
- What
- Stock recommendations with high upside potential
- When
- Not specified
- Where
- India
- Why
- Structural growth narratives in diverse sectors
- Stock
- Dr Reddy’s Laboratories
- Rating
- Buy
- Target Price
- Rs 1,522
- Upside Potential
- 22%
- Growth Drivers
- NRT business, biosimilar launches, India growth, gSemaglutide pen sales, pipeline products
- Stock
- Mahindra & Mahindra
- Rating
- Add
- Target Price
- Rs 4,032
- Upside Potential
- 8.5%
- Growth Drivers
- Automotive and Farm Equipment, global expansion, SUV portfolio, EV launches, farm revenue tripling, tech-led solutions
- Stock
- Eternal (Zomato)
- Rating
- Buy
- Target Price
- Rs 450
- Upside Potential
- 50%
- Growth Drivers
- Blinkit, consumer purchases shift, margin guidance, brand and customer monetisation